Researchers at Baycrest have made significant contributions to the understanding of paratonia, a common yet underrecognized condition in advanced dementia. The studies explore clinical features, recognition, and assessment approaches, emphasizing the need for more compassionate and person-centered care.
A Baycrest study found that subtle features of speech timing, such as pauses and fillers, are linked to executive function and predict cognitive decline. The research uses artificial intelligence to analyze natural speech patterns for early detection of dementia.
Dr. Allison Sekuler, President and Chief Scientist at Baycrest, has been elected a Fellow of the Canadian Academy of Health Sciences for her ground-breaking research on brain processing and cognitive decline. Her work aims to advance health outcomes for Canadians through innovation and equity in science.
Dr. Lei Wang joins Baycrest to champion scientific excellence in dementia research and promote healthy aging. With expertise in neuroimaging and data-driven approaches, he will drive BARE's strategic research plan.
A Baycrest study reveals that sleep actively enhances memory for event sequence, improving recall of everyday experiences. This discovery deepens our understanding of the critical role of sleep in integrating experiences into memory.
A Baycrest study reveals that vivid visual imagery is associated with a higher risk of developing PTSD, while individuals with strong spatial imagery are less likely to develop the disorder. This research provides valuable insights into how trauma processing and memory contribute to PTSD.
Baycrest leaders Dr. Allison Sekuler, Dr. Nicole Anderson, and Melissa Turzanski have been named winners of the WXN's Top 100 Awards for their groundbreaking work in aging and brain health research and innovation. Their contributions have transformed industries, communities, and country through exceptional leadership.